Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.




This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Byetta Prescribers for Diabetes (US)(?)

Council Members in this Study Group: 190

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

What is a GLG Leader?
Harold Bays, MD, FACP, President and Medical Director, L-MARC Research CenterHarold Bays, MD, FACP
President and Medical Director
L-MARC Research Center

Harold Bays, MD, FACE, FACP, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...

RoseMarie Pasmantier, MD
Director, Diabetes Outpatient Department
SUNY Downstate Medical Center - CC

RoseMarie Pasmantier, MD, is Director of the Diabetes Outpatient Department at State University of New York at Stony Brook. Dr. Pasmantier has experience in the treatment of all metabolic disorders. Her research interests include new treatments for type II diabetes and dyslipidemia. Dr. Pasmantier has...

Joseph Bass, MD, PhD
Division Head of Endocrinology and Metabolism
Evanston Northwestern Healthcare

Joseph Bass, MD, PhD, is Assistant Professor of Medicine and Neurobiology at Northwestern University in Illinois and Division Head of Endocrinology and Metabolism at Evanston Northwestern Healthcare. He is also the Director of a federally-funded basic research program on obesity, diabetes, and lipid...

Ronald Innerfield, MD, Chief, Clinical Trials & Epidemiology , The Dorothy Bullock Memorial National Diabetes CenterRonald Innerfield, MD
Chief, Clinical Trials & Epidemiology
The Dorothy Bullock Memorial National Diabetes Center

Ronald Innerfield, MD, FACE, is Chief of Clinical Trials and Epidemiology, Emeritus, at the National Diabetes Center. He is also Vice President of Clinical Affairs of Evidence Based Medicine, a site management organization (SMO) in Princeton. Dr. Innerfield was a primary medical reviewer at the Division...

Michael Dempsey, Medical Director, Johns Hopkins Diabetes Center at Suburban HospitalMichael Dempsey
Medical Director
Johns Hopkins Diabetes Center at Suburban Hospital

Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...

Dan Streja, MD
Clinical Professor of Medicine
University of California, Los Angeles

Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is the Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja...

Dean Traiger, MD, Owner, Physicians’ Primary Care of Southwest Florida,P.L.Dean Traiger, MD
Owner
Physicians’ Primary Care of Southwest Florida,P.L.

Dean Traiger, MD, is the Owner of Physician's Primary Care of Southwest Florida. Dr. Traiger is board certified in Family Practice and specializes in general primary care across the continuum of pediatrics, adolescent, and adult and geriatric care. He is also focused on diabetes care, hypertension,...

Richard Levy, MD
Assistant Professor of Medicine and Pediatrics
Rush University Medical Center

Richard Levy, MD, is an Assistant Professor of Medicine and Pediatrics at Rush University Medical Center, and is a privately practicing adult and pediatric endocrinologist and diabetologist in Illinois. Dr. Levy has conducted research on diabetes and lipid abnormalities and is currently participating...

GLG NewsSMAnalyses by this Study Group's Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Exenatide may provide practical and cost convenient efficacy in tratment of Metabolic Syndrome patients | 06-23-2008
Author: GLG Expert Contributor

More than 50% of patients have the 3 ccomponents to qualify for diagnosis of Metabolic Syndrome.Twwo of the components,Diabetes and Obesity are present in 20-25% of them and are difficult to control.Exenatide seems to provide that benefit.

Race to Market, with Competition Hot on Heels | 06-19-2008
Author: GLG Expert Contributor

As exciting as the DURATION I study results have been, Roche's GLP-1 agonist is also looking good in earlier phase trials, and there are MANY competitors in this GLP-1 realm, as well as the gliptins (oral, with similar efficacy on glucose and A1c but without the dramatic weight loss), chomping at the...

AGI-1067 May Address More than the Blood Sugar | 05-30-2008
Author: GLG Expert Contributor

This compound may have additiional benefit in type 2 diabetic patients, especially those with the cardiometabolic syndrome. 

Tekturna scripts | 05-28-2008
Author: GLG Expert Contributor

I am a heavy user of ARB's and Tekturna.  This article does not really show anything of significance.  Most practicing physicians have seen much better results and much better tolerability with ARB's than diuretics. I do not think this is going to change prescribing habits of anyone. ...

What a bunch of horse crap. | 05-19-2008
Author: GLG Expert Contributor

 Study will be ridiculed.   1) Comparator drug is not appropriate. 2) Not an outcomes study. 3) Time frame too short to be clinically significant. 4) Drug too expensive for first line use. 5) Long term safety not established.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Office Based Private Practice or Clinic
  • Academic Medical Center/Hospital or Clinic
  • Non-Academic Community Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Owner
  • Physician - Director
  • President
  • Partner
  • Physician - Division Head
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics